PCRX vs SMCI · P/E 174, rev $369.8M vs P/E 26, rev $39.06B
Pacira BioSciences, Inc. (PCRX) versus Super Micro Computer Inc (SMCI) — a side-by-side from cached financials, not a winner call.
Pacira BioSciences, Inc. (PCRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Super Micro Computer Inc (SMCI) is a computer hardware company listed on US. It is led by Charles Liang.
Latest reported PCRX revenue for 2026-06-30 was $369.8M. Net income was $7.6M. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.
Latest reported SMCI revenue for 2026-06-30 was $39.06B. Net income was $2.23B. Revenue was up 77.8% from 2025-06-30 to 2026-06-30. SMCI currently screens at market cap $28.98B and trailing P/E 26.4.
PCRX currently screens at market cap $890.8M and trailing P/E 174.2. SMCI currently screens at market cap $28.98B and trailing P/E 26.4.
Not investment advice. Open the PCRX and SMCI stock pages for the full models.
Not investment advice.